Because elevations in tau PET are so closely tied to the degree of cognitive impairment, the probability of meaningfully elevated tau PET (outside of the medial temporal lobe) is very low in persons with SCD (145), who by definition have normal objectively measured cognition. The gene discussed is MAPT; the disease is Cognitive impairment.